investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

The Mitochondrial Genome and Ovarian Cancer Risk

Catherine Phelan

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Simon Gayther

University College London

London, United Kingdom

Paul Pharoah

University of Cambridge

Cambridge, United Kingdom

Catherine Phelan

Moffitt Cancer Center

Tampa, United States

University of South Florida

Tampa, United States

Related projects

Thomas Spies

Stimulation of Tumorigenesis by NKG2D

Ovary

Pathology

Xiaolu Yang

Role of p53 Family Proteins in Glucose Metabolism

Ovary

Pathology

Meera Nanjundan

Transition from Endometriosis to Ovarian Cancer: Role of Iron-Induced Autophagy

Ovary

Pathology

Dipanjan Chowdhury

Molecular mechanism and relevance of microRNAs in DSB repair pathway choice

Ovary

Pathology

Jeffrey Gildersleeve

Serum Antibody Profiling with a Carbohydrate Microarray

Ovary

Pathology

Selvendiran Karuppaiyah

Dissecting the Role of STAT3 and Targeting Ovarian Cancer

Ovary

Pathology

Ram Prasad

Nanoprobe-amplified spectroscopic assay for accurate assessment of ovarian cancer burden in peripheral blood

Ovary

Pathology

Kylie Walters

Ubiquitin Signaling

Ovary

Pathology

Ernst Lengyel

Regulation of Adhesion and Proteolysis in Ovarian Cancer

Ovary

Pathology